MDA-MB-231 |
Growth inhibition assay |
|
72 hrs |
Growth inhibition of human MDA-MB-231 cells after 72 hrs by MTT assay, IC50 = 19.2 μM. |
27209562 |
MCF7 |
Growth inhibition assay |
|
72 hrs |
Growth inhibition of human MCF7 cells after 72 hrs by MTT assay, IC50 = 19.3 μM. |
27209562 |
MDA-MB-361 |
Growth inhibition assay |
|
72 hrs |
Growth inhibition of human MDA-MB-361 cells after 72 hrs by MTT assay, IC50 = 20.4 μM. |
27209562 |
T47D |
Growth inhibition assay |
|
72 hrs |
Growth inhibition of human T47D cells after 72 hrs by MTT assay, IC50 = 16.9 μM. |
27209562 |
GES-1 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human GES-1 cells after 72 hrs by MTT assay, IC50 = 13.12 μM. |
29310026 |
PC3 |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human PC3 cells assessed as growth inhibition after 48 hrs by MTT assay, IC50 = 9.32 μM. |
24148837 |
HeLa |
Antiproliferative assay |
|
48 hrs |
Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay, GI50 = 7.9 μM. |
29172080 |
MGC803 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay, IC50 = 7.72 μM. |
29310026 |
PC3 |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay, IC50 = 5.94 μM. |
29310026 |
hTERT-BJ |
Cytotoxicity assay |
|
48 hrs |
Cytotoxicity against human hTERT-BJ cells assessed as cell growth inhibition after 48 hrs SRB assay, GI50 = 4.5 μM. |
29172080 |
LNCAP |
Antiproliferative assay |
|
72 hrs |
Antiproliferative activity against human LNCAP cells after 72 hrs by MTT assay, IC50 = 3.29 μM. |
29310026 |
T47D |
Antiproliferative assay |
|
48 hrs |
Antiproliferative activity against human T47D cells after 48 hrs by SRB assay, GI50 = 24 μM. |
29172080 |
WiDr |
Antiproliferative assay |
|
48 hrs |
Antiproliferative activity against human WiDr cells after 48 hrs by SRB assay, GI50 = 42 μM. |
29172080 |
V79MZh11B2 |
Function assay |
|
|
Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells, IC50 = 1.751 μM. |
18672868 |
V79MZh |
Function assay |
|
|
Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate, IC50 = 1.75 μM. |
23859149 |
V79MZh |
Function assay |
|
|
Inhibition of human CYP11B2 expressed in hamster V79MZh cells, IC50 = 1.75 μM. |
20550118 |
V79MZh |
Function assay |
|
|
Inhibition of human CYP11B1 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate, IC50 = 1.61 μM. |
23859149 |
V79MZh |
Function assay |
|
|
Inhibition of human CYP11B1 expressed in hamster V79MZh cells, IC50 = 1.61 μM. |
20550118 |
V79MZh11B1 |
Function assay |
|
|
Inhibition of recombinant CYP11B1 expressed in expressed in V79MZh11B1 cells, IC50 = 1.608 μM. |
19211174 |
V79MZh11B1 |
Function assay |
|
|
Inhibition of human CYP11B1 expressed in hamster V79MZh11B1 cells, IC50 = 1.608 μM. |
18672868 |
P450c17-LNCaP |
Function assay |
|
|
In vitro cytochrome P450 17A1 inhibition was assayed using the rapid acetic acid releasing assay (AARA), utilizing intact P450c17-expressing Escherichia coli or P450c17-LNCaP cells as the enzyme source, IC50 = 0.8 μM. |
12773039 |
JM109 |
Function assay |
|
|
Inhibition of C-terminal His-tagged recombinant human CYP17A1delta19H mutant expressed in Escherichia coli JM109 cells assessed as decrease in progesterone hydroxylation in presence of cytochrome P450 reductase by HPLC-UV method, IC50 = 0.0094 μM. |
29792703 |